VolitionRX/$VNRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About VolitionRX
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
Ticker
$VNRX
Sector
Primary listing
AMEX
Employees
75
Headquarters
Website
VolitionRX Metrics
BasicAdvanced
$19m
-
-$4.37
1.33
-
Price and volume
Market cap
$19m
Beta
1.33
52-week high
$2.89
52-week low
$2.41
Financial strength
Current ratio
0.169
Quick ratio
0.117
Long term debt to equity
-22.058
Total debt to equity
-32.211
Interest coverage (TTM)
-8.73%
Profitability
EBITDA (TTM)
-20.755
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-1,352.16%
Operating margin (TTM)
-1,258.46%
Revenue per employee (TTM)
$20,000
Management effectiveness
Return on assets (TTM)
-166.70%
Return on equity (TTM)
76.19%
Valuation
Price to revenue (TTM)
7.514
Price to book
-0.45
Price to tangible book (TTM)
-0.44
Price to free cash flow (TTM)
-0.656
Free cash flow yield (TTM)
-152.33%
Free cash flow per share (TTM)
-3.702
Growth
Revenue change (TTM)
40.04%
Earnings per share change (TTM)
-29.85%
3-year revenue growth (CAGR)
77.98%
3-year earnings per share growth (CAGR)
-26.33%
10-year earnings per share growth (CAGR)
-8.60%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for VolitionRX stock?
VolitionRX (VNRX) has a market cap of $19M as of May 04, 2026.
What is the P/E ratio for VolitionRX stock?
The price to earnings (P/E) ratio for VolitionRX (VNRX) stock is 0 as of May 04, 2026.
Does VolitionRX stock pay dividends?
No, VolitionRX (VNRX) stock does not pay dividends to its shareholders as of May 04, 2026.
When is the next VolitionRX dividend payment date?
VolitionRX (VNRX) stock does not pay dividends to its shareholders.
What is the beta indicator for VolitionRX?
VolitionRX (VNRX) has a beta rating of 1.33. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.